Dr. Zhongsheng Tong
Claim this profileTianjin Medical University Cancer Institute & Hospital
Expert in Breast Cancer
Studies Cancer
12 reported clinical trials
23 drugs studied
Area of expertise
1Breast Cancer
Global LeaderStage IV
Stage III
HER2 negative
2Cancer
Stage III
Stage IV
HER2 negative
Clinical Trials Zhongsheng Tong is currently running
TROP2 ADC
for Cancer
A Phase I-II, First-in-Human Study of SKB264 in Patients with Locally Advanced Unresectable/Metastatic Solid Tumors who are refractory to Available Standard Therapies. Patient must have historically documented, incurable, locally advanced or metastatic cancer that are refractory to standard therapies of one of the following types: 1. Triple negative breast cancer 2. Epithelial ovarian cancer 3. Non-small cell lung cancer 4. Gastric adenocarcinoma/Gastroesophageal junction adenocarcinoma 5. Small cell lung cancer 6. HR+/ HER2-breast cancer 7. Head and neck squamous cell carcinoma 8. Endometrial carcinoma 9. Urothelial carcinoma
Recruiting1 award Phase 1 & 213 criteria
Afuresertib + Fulvestrant
for Breast Cancer
This trial tests a combination of two drugs, afuresertib and fulvestrant, for patients with a specific type of breast cancer who haven't responded to other treatments. The drugs work together to block cancer cell growth by targeting different pathways. Fulvestrant is an effective drug used for treating hormone receptor-positive, HER2-negative advanced breast cancer, often in combination with other targeted therapies.
Recruiting1 award Phase 314 criteria
More about Zhongsheng Tong
Clinical Trial Related4 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Zhongsheng Tong has experience with
- Tucatinib
- Placebo
- Afuresertib
- SKB264
- Oral Paclitaxel
- Paclitaxel Injection
Breakdown of trials Zhongsheng Tong has run
Breast Cancer
Cancer
Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Zhongsheng Tong specialize in?
Zhongsheng Tong focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are Stage III.
Is Zhongsheng Tong currently recruiting for clinical trials?
Yes, Zhongsheng Tong is currently recruiting for 2 clinical trials in Tianjin Tianjin. If you're interested in participating, you should apply.
Are there any treatments that Zhongsheng Tong has studied deeply?
Yes, Zhongsheng Tong has studied treatments such as Tucatinib, Placebo, Afuresertib.
What is the best way to schedule an appointment with Zhongsheng Tong?
Apply for one of the trials that Zhongsheng Tong is conducting.
What is the office address of Zhongsheng Tong?
The office of Zhongsheng Tong is located at: Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin 300181 China. This is the address for their practice at the Tianjin Medical University Cancer Institute & Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.